Genetic technologies files provisional patent for its covid-19 severity risk test with patent office in australia

Genetic technologies provides update on covid-19 disease severity test.genetic technologies ltd - filed a provisional patent for its covid-19 severity risk test with patent office in australia.genetic technologies - in discussions with international biobanks and clinical laboratories to source an independent cross-validation dataset.genetic technologies ltd - options for clinical risk model currently being evaluated.genetic technologies ltd - commenced ordering its first snp array panel from us-based thermo fisher scientific.genetic technologies ltd - confirmed capacity to scale up production for global-roll out of covid-19 severity risk test with major manufacturers.
TMO Ratings Summary
TMO Quant Ranking